Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$774,936
+$37,107 QoQ
Shares Held
2,140
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,873
of 3,140 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Klingman & Associates, LLC holds $15,277,947 across 11 Drug Manufacturers - General names. AMGN ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,448 | $4,431,268 | |
| 2 | ABBV |
AbbVie Inc.
|
13,168 | $3,313,595 | |
| 3 | LLY |
ELI LILLY & Co
|
2,410 | $2,890,626 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,463 | $1,344,495 | |
| 5 | AMGN |
Amgen Inc
This page
|
2,140 | $774,936 | |
| 6 | NVS |
Novartis AG
|
4,523 | $708,844 | |
| 7 | PFE |
Pfizer Inc
|
28,237 | $679,946 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,664 | $336,569 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $774,936 | 2,140 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $737,829 | 2,097 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $663,130 | 2,026 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $543,799 | 1,927 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $517,934 | 1,855 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $420,592 | 1,350 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $309,119 | 1,186 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $386,007 | 1,198 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $373,690 | 1,196 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $354,831 | 1,248 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $341,303 | 1,185 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $315,255 | 1,173 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $266,424 | 1,200 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $226,519 | 937 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $231,385 | 881 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $208,044 | 923 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $219,699 | 903 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $218,847 | 905 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $314,733 | 1,399 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $243,271 | 1,144 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $278,850 | 1,144 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $284,638 | 1,144 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $259,579 | 1,129 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $288,725 | 1,136 | Shares | Sole | 2020-11-03 | |
| No filing history on record for this holder in this stock. | ||||||